Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers

par Crosbie, Philip A.J., Shah, Rajesh, Summers, Yvonne, Dive, Caroline, Blackhall, Fiona
Publié dans Transl Lung Cancer Res (2013)

Cerebral air embolism following transbronchial lung biopsy during flexible bronchoscopy

par Evison, Matthew, Crosbie, Philip A.J., Bright-Thomas, Rowland, Alaloul, Mohamed, Booton, Richard
Publié 2014

A study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA

par Evison, Matthew, Crosbie, Philip A J, Morris, Julie, Martin, Julie, Barber, Philip V, Booton, Richard
Publié 2014

Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors

par Lebrett, Mikey B, Crosbie, Emma J, Smith, Miriam J, Woodward, Emma R, Evans, D Gareth, Crosbie, Philip A J
Publié dans J Med Genet (2021)

Biomarkers in lung cancer screening: the importance of study design

par Baldwin, David R, Callister, Matthew E, Crosbie, Philip A, O’Dowd, Emma L, Rintoul, Robert C, Robbins, Hilary A, Steele, Robert J C
Publié dans Eur Respir J (2021)

ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing

par Crosbie, Philip A J, Crosbie, Emma J, Aspinall-O'Dea, Mark, Walker, Michael, Harrison, Rebecca, Pernemalm, Maria, Shah, Rajesh, Joseph, Leena, Booton, Richard, Pierce, Andrew, Whetton, Anthony D
Publié dans BMJ Open Respir Res (2016)

Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom

par Robbins, Hilary A., Alcala, Karine, Swerdlow, Anthony J., Schoemaker, Minouk J., Wareham, Nick, Travis, Ruth C., Crosbie, Philip A. J., Callister, Matthew, Baldwin, David R., Landy, Rebecca, Johansson, Mattias
Publié dans Br J Cancer (2021)

Correction: Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom

par Robbins, Hilary A., Alcala, Karine, Swerdlow, Anthony J., Schoemaker, Minouk J., Wareham, Nick, Travis, Ruth C., Crosbie, Philip A. J., Callister, Matthew, Baldwin, David R., Landy, Rebecca, Johansson, Mattias
Publié dans Br J Cancer (2021)

KRAS induces lung tumorigenesis through microRNAs modulation

par Shi, Lei, Middleton, Justin, Jeon, Young-Jun, Magee, Peter, Veneziano, Dario, Laganà, Alessandro, Leong, Hui-Sun, Sahoo, Sudhakar, Fassan, Matteo, Booton, Richard, Shah, Rajesh, Crosbie, Philip A. J., Garofalo, Michela
Publié dans Cell Death Dis (2018)

Yorkshire Enhanced Stop Smoking (YESS) study: a protocol for a randomised controlled trial to evaluate the effect of adding a personalised smoking cessation intervention to a lung...

par Murray, Rachael L, Brain, Kate, Britton, John, Quinn-Scoggins, Harriet D, Lewis, Sarah, McCutchan, Grace M, Quaife, Samantha L, Wu, Qi, Ashurst, Alex, Baldwin, David, Crosbie, Philip A J, Neal, Richard D, Parrott, Steve, Rogerson, Suzanne, Thorley, Rebecca, Callister, Matthew EJ
Publié dans BMJ Open (2020)

Analysis of lung cancer risk model (PLCO(M2012) and LLP(v2)) performance in a community-based lung cancer screening programme

par Lebrett, Mikey B, Balata, Haval, Evison, Matthew, Colligan, Denis, Duerden, Rebecca, Elton, Peter, Greaves, Melanie, Howells, John, Irion, Klaus, Karunaratne, Devinda, Lyons, Judith, Mellor, Stuart, Myerscough, Amanda, Newton, Tom, Sharman, Anna, Smith, Elaine, Taylor, Ben, Taylor, Sarah, Walsham, Anna, Whittaker, James, Barber, Phil V, Tonge, Janet, Robbins, Hilary A, Booton, Richard, Crosbie, Philip A J
Publié dans Thorax (2020)